Published in Chem Commun (Camb) on November 02, 2015
Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities. Int J Nanomedicine (2016) 0.75
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol (2005) 3.93
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. Lancet Oncol (2013) 3.24
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol (2009) 2.80
C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy. J Urol (2005) 1.93
Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis (2002) 1.85
The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radic Biol Med (2006) 1.78
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. Arthritis Rheum (2012) 1.61
Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem (2005) 1.53
Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins. Int J Cancer (2007) 1.43
Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging. J Am Coll Cardiol (2008) 1.41
Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology (2007) 1.26
A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging. Eur J Pharm Biopharm (2008) 1.23
Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol (2004) 1.23
Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res (2002) 1.22
Dasatinib: an anti-tumour agent via Src inhibition. Curr Drug Targets (2011) 1.15
Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer. J Clin Oncol (2006) 1.14
Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells. Cancer Lett (2011) 1.11
TORCH study: how much longer should we continue to use erlotinib in unselected patients with non-small-cell lung cancer? J Clin Oncol (2012) 1.07
In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions. Blood (2011) 1.06
Target therapies in pancreatic carcinoma. Curr Med Chem (2014) 1.01
Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies. J Clin Oncol (2007) 0.99
Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liver. J Pharmacol Exp Ther (2006) 0.96
In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging. Mol Imaging (2009) 0.94
Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study. Nanoscale (2010) 0.94
Poly-beta-cyclodextrin based platform for pH mapping via a ratiometric 19F/1H MRI method. Chem Commun (Camb) (2009) 0.92
Present status and perspectives in the treatment of hormone-refractory prostate cancer. Oncology (2005) 0.92
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design. J Clin Oncol (2002) 0.92
Role of gemcitabine in metastatic breast cancer patients: a short review. Breast (2007) 0.92
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma. Cancer (2009) 0.92
Dendritic polyglycerolsulfate near infrared fluorescent (NIRF) dye conjugate for non-invasively monitoring of inflammation in an allergic asthma mouse model. PLoS One (2013) 0.91
Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic Biol Med (2003) 0.90
The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection. BMC Microbiol (2010) 0.90
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis. Expert Opin Biol Ther (2014) 0.89
Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI. J Magn Reson Imaging (2008) 0.88
4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. Free Radic Biol Med (2005) 0.88
Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Radiology (2003) 0.87
Double phase transfer of gold nanorods for surface functionalization and entrapment into PEG-based nanocarriers. Chem Commun (Camb) (2009) 0.87
Nanosponge formulations as oxygen delivery systems. Int J Pharm (2010) 0.86
Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin. BMC Complement Altern Med (2013) 0.86
Well-defined, multifunctional nanostructures of a paramagnetic lipid and a lipopeptide for macrophage imaging. J Am Chem Soc (2009) 0.86
Microbubble-mediated oxygen delivery to hypoxic tissues as a new therapeutic device. Conf Proc IEEE Eng Med Biol Soc (2008) 0.85
Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma. MAGMA (2008) 0.85
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles. PLoS One (2013) 0.85
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients. Cancer Chemother Pharmacol (2005) 0.85
Clinical Evidence Supporting the Role of Lonidamine for the Treatment of BPH. Rev Urol (2005) 0.83
Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer. Nanomedicine (2011) 0.83
Weak polyion multilayer-assisted in situ synthesis as a route toward a plasmonic Ag/TiO2 photocatalyst. Langmuir (2010) 0.83
A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history. Fam Cancer (2011) 0.83
Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial. Oncologist (2006) 0.82
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study. Lung Cancer (2011) 0.82
Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents. Invest Radiol (2005) 0.82
Responsive Mn(II) complexes for potential applications in diagnostic Magnetic Resonance Imaging. Bioorg Med Chem (2010) 0.82
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review. Tumori (2012) 0.81
Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging. J Med Chem (2004) 0.81
New cyclodextrin dimers and trimers capable of forming supramolecular adducts with shape-specific ligands. Org Biomol Chem (2008) 0.81
In vivo tracking of murine adipose tissue-derived multipotent adult stem cells and ex vivo cross-validation. Int J Mol Imaging (2013) 0.81
Click chemistry for the assembly of gold nanorods and silver nanoparticles. Chemistry (2011) 0.81
High relaxivity supramolecular adducts between human-liver fatty-acid-binding protein and amphiphilic Gd(III) complexes: structural basis for the design of intracellular targeting MRI probes. Chemistry (2012) 0.81
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study. J Cancer Res Clin Oncol (2014) 0.81
Efficacy and safety of the combination of docetaxel (Taxotere) with targeted therapies in the treatment of solid malignancies. Curr Drug Targets (2009) 0.80
Release of toxic Gd3+ ions to tumour cells by vitamin B12 bioconjugates. Chemistry (2009) 0.80
Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancer. Breast J (2009) 0.80
CULEX-completely user-independent layers extraction: ultrasonic carotid artery images segmentation. Conf Proc IEEE Eng Med Biol Soc (2005) 0.80
Preclinical profile and clinical potential of gadocoletic acid trisodium salt (B22956/1), a new intravascular contrast medium for MRI. Acad Radiol (2002) 0.80
Design and testing of paramagnetic liposome-based CEST agents for MRI visualization of payload release on pH-induced and ultrasound stimulation. J Biol Inorg Chem (2013) 0.79
Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function. Invest Radiol (2002) 0.79
Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC). Support Care Cancer (2015) 0.79
IMAGE-WARP: a real-space restoration method for high-resolution STEM images using quantitative HRTEM analysis. Ultramicroscopy (2005) 0.79
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group. Cancer Chemother Pharmacol (2009) 0.78
Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike? Med Oncol (2013) 0.78
Bioinspired organocatalytic asymmetric reactions. Org Biomol Chem (2012) 0.78
First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale. Lung Cancer (2009) 0.78
Safety and activity of the combination of pegylated liposomal doxorubicin and weekly docetaxel in advanced breast cancer. Breast Cancer Res Treat (2004) 0.78
Damaging effects of gliadin on three-dimensional cell culture model. World J Gastroenterol (2005) 0.78
MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors. Expert Opin Ther Targets (2015) 0.78
In Vitro and In Vivo Assessment of Nonionic Iodinated Radiographic Molecules as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Tumor Perfusion Agents. Invest Radiol (2016) 0.77
Pharmacokinetic and metabolism determinants of fluoropyrimidines and oxaliplatin activity in treatment of colorectal patients. Curr Drug Metab (2011) 0.77
Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma. Tumori (2005) 0.77
Novel plant-derived target drugs: a step forward from licorice? Expert Opin Ther Targets (2013) 0.77
How should we prescribe lapatinib to our patients: once daily or twice daily, and at what dose? J Clin Oncol (2008) 0.77
Photochemical activation of endosomal escape of MRI-Gd-agents in tumor cells. Magn Reson Med (2011) 0.77
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study. Tumori (2015) 0.77
Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography. Invest Radiol (2006) 0.77
X-ray fluorescence elemental mapping and microscopy to follow hepatic disposition of a Gd-based magnetic resonance imaging contrast agent. Clin Exp Pharmacol Physiol (2011) 0.77
A general strategy for obtaining biodegradable polymer shelled microbubbles as theranostic devices. Chem Commun (Camb) (2013) 0.77
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial. J Transl Med (2003) 0.77
Cubosomes for in vivo fluorescence lifetime imaging. Nanotechnology (2016) 0.77
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA). Lung Cancer (2010) 0.77
Conjugated PDT drug: photosensitizing activity and tissue distribution of PEGylated pheophorbide a. Cancer Biol Ther (2010) 0.77
Pharmacogenomics of cetuximab in metastatic colorectal carcinoma. Pharmacogenomics (2014) 0.77